Last reviewed · How we verify
Ropivacaine Hcl 0.2% Inj Vil 10Ml — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Ropivacaine Hcl 0.2% Inj Vil 10Ml (Ropivacaine Hcl 0.2% Inj Vil 10Ml) — Surgery Bitenc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ropivacaine Hcl 0.2% Inj Vil 10Ml TARGET | Ropivacaine Hcl 0.2% Inj Vil 10Ml | Surgery Bitenc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ropivacaine Hcl 0.2% Inj Vil 10Ml CI watch — RSS
- Ropivacaine Hcl 0.2% Inj Vil 10Ml CI watch — Atom
- Ropivacaine Hcl 0.2% Inj Vil 10Ml CI watch — JSON
- Ropivacaine Hcl 0.2% Inj Vil 10Ml alone — RSS
Cite this brief
Drug Landscape (2026). Ropivacaine Hcl 0.2% Inj Vil 10Ml — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-hcl-0-2-inj-vil-10ml. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab